Rhythm Pharmaceuticals, Inc. (RYTM)

Healthcare · Biotechnology · NASDAQ

Rhythm Pharmaceuticals, Inc. (RYTM) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $7.96B and a free-cash-flow yield of -1.6%. Over the most recent reported fiscal year, revenue grew 45.8%.

Market cap	$7.96B
Trailing P/E	—
FCF yield	-1.6%
Revenue growth (YoY)	+45.8%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live RYTM data on Nama Insights →